Dr. Anna Frisch, MD

• Endocrinology, Diabetes & Metabolism

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Private Practice - Group/partnership

• Emory University Hospital

  Fellowship Hospital, 2009

• Emory University School Of Medicine

  2009

• University Of Connecticut Affiliate Saint Vincent S Medical Center

  2007

• Saint Vincents Medical Center

  Internship Hospital, 2005

• Medical University Of Lodz, Faculty Of Medicine

  Medical School, 1999

• English

• Polish

• Diabetic platelets are less sensitive to acetylsalicylic acid (Aspirin®) – the possible role of glycaemic control, 2001

• . Glucose impaired tolerance and overt diabetes incidence in patients recovered from acute pancreatitis, 2001

• Hyperglycemia and Postoperative Complications in Non-Cardiac Surgery, 2009

• Management of Breast abscesses in non-lactating women, 2009

• Hypertension in diabetes – pathogenesis and treatment, 2002

• Breast Abscess in Non-Lactating Women with Diabetes: Clinical Features and Outcome., 2009

• Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (Asprin®) – its relation to metabolic control., 2004

• Resistance or reduced sensitivity to aspirin occurs more frequently in diabetic patients and is related to nonenzymatic protein glycosylation, 2000

• New mechanisms of action of sulfonylureas, 2001

• Breast Abscess in Non-Lactating Women with Diabetes: Clinical Features and Outcome, 2008

• Relation between admission blood glucose, lipids, blood pressure and stroke type, neurological impairment, and mortality in type 2 diabetes, 2001

• Contaminated Heroin: Cardiovascular and Metabolic Effects., 2006

• Low sensitivity of fasting versus post-load criteria for diagnosis glucose intolerance in high risk subjects, 2000

• Borderline glucose intolerance and 24-hour blood pressure rhythm, 2001

• . Admission glycaemia, stroke subtypes and mortality in diabetes and non-diabetes acute stroke subjects, 2000

• . Endocrine pancreatic function in patients after acute pancreatitis, 1999

• Activity of sodium-lithium countertransport in erythrocytes as a marker of diabetic nephropathy, 1998

• Endocrine pancreatic function in patients after acute pancreatitis, 2002

• The effect of time interval between insulin injection and meal ingestion on metabolic control in type 2 diabetes mellitus patients, 2000

• Ischaemic heart disease in diabetic patients –methods of treatment, 2000

• Blood lipids in diabetic and non-diabetic acute stroke patients, 2002

• Long-term effects of metformin treatment on metabolic control, body weight and insulin requirement in type 2 diabetes mellitus, 1999

• Proliferative activity of colon mucosa – methods of estimation, factors and regulative mechanisms, clinical implications, 1999

• Blood lipids in diabetic and non-diabetic acute stroke patients, 2002

• Body mass and cricardial blood pressure rhythm in type 2 diabetic patients, 2002

• Lacunar stroke in diabetics and non-diabetics patients, 2001

• Determination of reduced and oxidized species of cysteine and homocysteine in human urine by HPLC with ultraviolet detection, 2001

• . Poor sensitivity of new ADA criteria for glucose intolerance diagnosis, 1999

• Perioperative Hyperglycemia and Mortality Risk in Non-Cardiac Surgical Patients., 2009

• Breast abscesses in non-lactating women with diabetes: clinical features and outcome, 2009

• Relation between plasma levels of CRP, IL-6 and fibrinogen and stroke type and neurological impairment in diabetic and non-diabetic acute stroke patients, 2002

• Stroke- dangerous complication of diabetes, 2000

• Insulinotheraphy in diabetes, 2000